#United States #New York #Gross Law Firm #Securities Class Action #Altimmune

Warning to Altimmune, Inc. Investors

On September 22, 2025, The Gross Law Firm released an important announcement for Altimmune, Inc. (NASDAQ: ALT) shareholders regarding an impending class action lawsuit. This notice particularly concerns those who acquired shares during the defined class period, which spans from August 10, 2023, to June 25, 2025. Investors are urged to contact the firm quickly if they wish to be considered for appointment as a lead plaintiff.

Understanding the Allegations

The lawsuit follows a critical press release from Altimmune on June 26, 2025, where the company disclosed disappointing topline results from their IMPACT Phase 2b MASH trial concerning Pemvidutide's effectiveness. Despite previous promises of strong outcomes, the results indicated a lack of statistical significance in the primary endpoint related to fibrosis reduction. This significant overshoot in expectations led to a steep 53.2% drop in Altimmune's stock price, from $7.71 per share on June 25, 2025, to just $3.61 the next day.

Details of the Class Action

The forthcoming legal action highlights these pressing concerns and encourages shareholders affected by this loss to register. The registration process is essential, not only to enable participation in possible recovery but also to ensure ongoing updates throughout the case's lifespan via monitoring software. Importantly, investors should note that there is no obligation or cost associated with being a part of this case.

Deadline to Act

Shareholders must act promptly, as the deadline to file for lead plaintiff status is on October 6, 2025. This date signifies a critical moment for investors aiming to reclaim losses attributed to misleading information and company actions that inflated stock prices misleadingly.

Benefits of Registration

Once registered, shareholders will benefit from systematic updates about the case's progress. They can remain informed about potential developments and have a clear pathway to understanding their entitlements in the pending litigation.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its dedication to protecting the rights of investors scammed through deceitful business practices. They have a strong commitment to ensuring that companies are held accountable for their actions, thus supporting investors who have faced losses stemming from inflated stock prices due to false or misleading representations. The firm seeks to recover losses for those whose investments were impacted by unethical corporate conduct.

Getting in Touch

Shareholders concerned about their investments in Altimmune or those wishing to learn more about the lawsuit can reach The Gross Law Firm using the information provided. Anyone wanting to register can visit their official site to submit their information, has been made simple and accessible.

Conclusion

As Altimmune navigates the implications of these trial results, affected investors should not hesitate to engage with this class action suit. Time is of the essence; thereby, registering sooner rather than later could be crucial to protecting their investments against the fallout of misleading corporate behavior.